Akoya Biosciences
Stock Forecast, Prediction & Price Target

Akoya Biosciences (AKYA) stock Price Target by analysts

Last Year
Average Price Target

$4

Potential upside: 210.10%

Based on 1 analysts

Akoya Biosciences price prediction

Strike.market

What is Akoya Biosciences stock analysts` prediction?

Akoya Biosciences stock forecast: Based on 1 Wall Street analysts` predicted price targets for Akoya Biosciences in the last 3 months, the avarage price target is $4, with a high forecast of $NaN. The average price target represents a 210.10% change from the last price of $1.29.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Akoya Biosciences stock Price Target by analysts

Full breakdown of analysts given Akoya Biosciences price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
Dave Westenberg
Piper Sandler
0%
0/1
10 months ago $4 210.10% upside $2.32 StreetInsider
Previous targets (0)
Tejas Savant
Morgan Stanley
0%
0/2
about 1 year ago $3 132.57% upside $2.01 StreetInsider
Previous targets (1)
Bill Bonello
Craig-Hallum
0%
0/1
about 1 year ago $7.5 481.44% upside $2.23 TheFly
Previous targets (0)
Tejas Savant
Morgan Stanley
0%
0/2
over 1 year ago $4 210.10% upside $2.15 StreetInsider
Previous targets (1)
Kyle Mikson
Canaccord Genuity
0%
0/1
over 1 year ago $6 365.15% upside $4.12 StreetInsider
Previous targets (0)
Mark Massaro
BTIG
0%
0/1
over 1 year ago $6 365.15% upside $4.12 StreetInsider
Previous targets (0)
David Westenberg
Piper Sandler
0%
0/1
about 3 years ago $17 1217.93% upside $13.34 TheFly
Previous targets (0)

Akoya Biosciences Financial Estimates

Akoya Biosciences Revenue Estimates

Akoya Biosciences EBITDA Estimates

Akoya Biosciences Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$54.91M
 
N/A
$74.85M
 
36.31%
$96.63M
 
29.08%
Avg: $124.30M
Low: $120.17M
High: $131.16M
avg. 28.63%
Avg: $147.47M
Low: $140.67M
High: $154.32M
avg. 18.64%
Avg: $154.4M
Low: $147.27M
High: $161.57M
avg. 4.69%
Avg: $171.5M
Low: $163.58M
High: $179.46M
avg. 11.07%
Net Income
 
% change YoY
$-42.93M
 
N/A
$-70.64M
 
-64.53%
$-63.32M
 
10.35%
Avg: $-35.77M
Low: $-41.76M
High: $-21.32M
avg. 43.50%
Avg: $-22.23M
Low: $-28.88M
High: $-5.77M
avg. 37.84%
Avg: $-15.10M
Low: $-16.01M
High: $-14.20M
avg. 32.04%
Avg: $-8.44M
Low: $-8.95M
High: $-7.93M
avg. 44.11%
EBITDA
 
% change YoY
$-32.90M
 
N/A
$-59.33M
 
-80.29%
$-45.63M
 
23.09%
Avg: $-57.57M
Low: $-60.75M
High: $-55.66M
avg. -26.16%
Avg: $-68.30M
Low: $-71.47M
High: $-65.15M
avg. -18.64%
Avg: $-71.51M
Low: $-74.83M
High: $-68.21M
avg. -4.69%
Avg: $-79.43M
Low: $-83.12M
High: $-75.76M
avg. -11.07%
EPS
 
% change YoY
-$1.15
 
N/A
-$1.87
 
-62.60%
-$1.43
 
23.52%
Avg: -$0.68
Low: -$0.94
High: -$0.48
avg. 52.14%
Avg: -$0.36
Low: -$0.65
High: -$0.13
avg. 47.09%
Avg: -$0.34
Low: -$0.36
High: -$0.32
avg. 6.07%
Avg: -$0.19
Low: -$0.2
High: -$0.18
avg. 44.11%
Operating Expenses
 
% change YoY
$71.44M
 
N/A
$109.59M
 
53.40%
$104.27M
 
-4.86%
Avg: $100.29M
Low: $96.96M
High: $105.83M
avg. -3.80%
Avg: $118.99M
Low: $113.50M
High: $124.52M
avg. 18.64%
Avg: $124.58M
Low: $118.83M
High: $130.37M
avg. 4.69%
Avg: $138.38M
Low: $131.99M
High: $144.80M
avg. 11.07%

FAQ

What is Akoya Biosciences stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 39.38% in 2025-2028.

We have gathered data from 7 analysts. Their low estimate is -41.76M, average is -35.77M and high is -21.32M.

What is Akoya Biosciences stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 15.76% in 2025-2028.

We have gathered data from 7 analysts. Their low revenue estimate is $120.17M, average is $124.30M and high is $131.16M.

What is Akoya Biosciences stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 37.36% in 2025-2028.

We have gathered data from 7 analysts. Their low earnings per share estimate is -$0.94, average is -$0.68 and high is $-0.48.

What is the best performing analyst?

In the last twelve months 1 analysts have been covering Akoya Biosciences stock. The most successful analyst is Dave Westenberg.